The tweet was deleted by the author.
But we saved everything 🙂.
Eastman Kodak is expanding its role in the pharmaceutical sector by offering high-quality, U.S.-made key starting materials (KSMs) that support drug companies in accelerating innovation and reducing risk.
The company highlights that its expertise in chemistry and commitment to domestic manufacturing allows pharmaceutical firms to maintain consistent quality standards while optimizing production processes. Eastman Kodak's focus on operational excellence positions it as a reliable partner for companies seeking stability in their supply chains.
Kodak’s continued diversification into pharmaceuticals builds on a foundation of chemical expertise long recognized for driving innovation through its legacy in film and imaging technologies. This approach reflects the company’s broader strategy, as previously demonstrated in leveraging its film expertise for growth in printing and materials (innovation through decades of film expertise), while also placing value on operational excellence supported by employee recognition initiatives (contribution advancing innovation and manufacturing).